all 2 comments

[–]IkeConn 2 insightful - 2 fun2 insightful - 1 fun3 insightful - 2 fun -  (0 children)

But the profits have spoken.

[–]iamonlyoneman[S] 1 insightful - 1 fun1 insightful - 0 fun2 insightful - 1 fun -  (0 children)

...a panel of outside experts for the FDA concluded that a pivotal study of aducanumab failed to show strong evidence that the drug worked, citing questionable efficacy and multiple red flags found with the data analysis.[13] There were also significant health risks associated with the drug; brain swelling or brain bleeding was found in 41% of patients enrolled in the studies.[14] Nevertheless, the drug was approved...